These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33641859)

  • 1. Social determinants of multidrug-resistant tuberculosis: A scoping review and research gaps.
    Najafizada M; Rahman A; Taufique Q; Sarkar A
    Indian J Tuberc; 2021 Jan; 68(1):99-105. PubMed ID: 33641859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.
    Keshavjee S; Gelmanova IY; Pasechnikov AD; Mishustin SP; Andreev YG; Yedilbayev A; Furin JJ; Mukherjee JS; Rich ML; Nardell EA; Farmer PE; Kim JY; Shin SS
    Ann N Y Acad Sci; 2008; 1136():1-11. PubMed ID: 17954675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributing risk factors towards the prevalence of multidrug-resistant tuberculosis in Malaysia: A systematic review.
    Rajendran M; Zaki RA; Aghamohammadi N
    Tuberculosis (Edinb); 2020 May; 122():101925. PubMed ID: 32275233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review.
    Thomas BE; Shanmugam P; Malaisamy M; Ovung S; Suresh C; Subbaraman R; Adinarayanan S; Nagarajan K
    PLoS One; 2016; 11(1):e0147397. PubMed ID: 26807933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review.
    Di Gennaro F; Pizzol D; Cebola B; Stubbs B; Monno L; Saracino A; Luchini C; Solmi M; Segafredo G; Putoto G; Veronese N
    Tuberculosis (Edinb); 2017 Mar; 103():44-51. PubMed ID: 28237033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study.
    Stosic M; Vukovic D; Babic D; Antonijevic G; Foley KL; Vujcic I; Grujicic SS
    BMC Public Health; 2018 Sep; 18(1):1114. PubMed ID: 30208864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control.
    Sharma SK; Mohan A
    Chest; 2006 Jul; 130(1):261-72. PubMed ID: 16840411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China.
    Hutchison C; Khan MS; Yoong J; Lin X; Coker RJ
    BMC Public Health; 2017 Feb; 17(1):221. PubMed ID: 28222724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-urban variation in tuberculosis and community socioeconomic deprivation in Lisbon metropolitan area: a Bayesian approach.
    Oliveira O; Ribeiro AI; Duarte R; Correia-Neves M; Rito T
    Infect Dis Poverty; 2022 Mar; 11(1):24. PubMed ID: 35321758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Previous Smoking Habit and Perceived Social Discrimination with the Risk of Multi-Drug Resistant Tuberculosis in Central Nepal.
    Marahatta SB; Adhikari B; Mishra SR; Raut S; Ramasoota P; Malla P; Kaewkungwal J; Singhasivanon P
    J Nepal Health Res Counc; 2015; 13(29):95-101. PubMed ID: 26411721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants.
    Atre SR; Mistry NF
    J Public Health Policy; 2005 Apr; 26(1):96-114. PubMed ID: 15906879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage.
    Fuady A; Houweling TAJ; Mansyur M; Richardus JH
    Infect Dis Poverty; 2018 Jan; 7(1):3. PubMed ID: 29325589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-drug resistant tuberculosis burden and risk factors: an update.
    Marahatta SB
    Kathmandu Univ Med J (KUMJ); 2010; 8(29):116-25. PubMed ID: 21209520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis.
    Pradipta IS; Forsman LD; Bruchfeld J; Hak E; Alffenaar JW
    J Infect; 2018 Dec; 77(6):469-478. PubMed ID: 30339803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multidrug-resistant tuberculosis].
    Alcaide F; Santín M
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():54-60. PubMed ID: 19100168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
    Chang KC; Yew WW
    Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding.
    Caminero JA
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):382-90. PubMed ID: 20202293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance among persons with tuberculosis in California, 1994-2003.
    Granich RM; Oh P; Lewis B; Porco TC; Flood J
    JAMA; 2005 Jun; 293(22):2732-9. PubMed ID: 15941802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing the spread of multidrug-resistant tuberculosis and protecting contacts of infectious cases.
    Fox GJ; Schaaf HS; Mandalakas A; Chiappini E; Zumla A; Marais BJ
    Clin Microbiol Infect; 2017 Mar; 23(3):147-153. PubMed ID: 27592087
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.